Fresenius Kabi: Morphine Sulfate Injection USP, Simplist® 2 mg/1 mL — FDA announcement Aug 5, 2026

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Aug 5, 2026. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Morphine Sulfate Injection USP, Simplist® 2 mg/1 mL
Reason
Due to a label mix-up
Classification
Not supplied
Recalling firm
Fresenius Kabi
Quantity
Not supplied
Agency-reported status
Company recall announcement
Source record identifier
5b292dd0c8c4fbde

Open the official record

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityFOR IMMEDIATE RELEASE – 8/4/2026 – LAKE ZURICH, Ill.— Fresenius Kabi, an operating company of the Fresenius Group, is voluntarily recalling one lot of Morphine Sulfate Injection USP, Simplist® 2 mg/1 mL due to a label mix-up. The MicroVault labeled as Morphine 2 mg/1 mL, may contain a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL. This recall is being conducted to the user level.; Use of a MicroVault labeled as Morphine Sulfate Injection 2 mg/mL containing a prefilled syringe of Dilaudid (hydromorphone HCl) 0.5 mg/0.5 mL has a reasonable probability of causing serious adverse health consequences, including life-threatening respiratory depression and death. Patients at greatest risk include individuals who do not use opioids on a regular basis, those with underlying respiratory disease, pediatric patients, and those who are also taking central nervous system (CNS) depressants. To date, no adverse event reports have been received for this lot number.; Product Name/Product Size | Unit of Use NDC Number | Unit of Sale NDC Number | Product Code | Lot Number | Expiration Date | First Ship Date | Last Ship Date; Morphine Sulfate Injection USP, Simplist® 2 mg / 1 mL, 1 mL fill in a single dose 1 mL Simplist® prefilled syringe | 76045- 004-01 | 76045- 004-11 | 764411 | 6402820 | 12/2028 | 01/29/2026 | 06/09/2026

Match all identifying details in the current notice. A brand name alone is not enough.

Product tables from the announcement

These identifying details come from the company announcement posted by FDA. Check the current notice for revisions.

FDA company announcement, table 1
Product Name/Product Size Unit of Use NDC Number Unit of Sale NDC Number Product Code Lot Number Expiration Date First Ship Date Last Ship Date
Morphine Sulfate Injection USP, Simplist® 2 mg / 1 mL, 1 mL fill in a single dose 1 mL Simplist® prefilled syringe 76045- 004-01 76045- 004-11 764411 6402820 12/2028 01/29/2026 06/09/2026

Announcement retrieved Oct 1, 2026. Official announcement.

Distribution

Not supplied

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Fda listing date
Aug 5, 2026
Company announcement date
Aug 4, 2026

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records